首页> 美国卫生研究院文献>Toxicological Sciences >Quantification of Low-Level Drug Effects Using Real-Time in vitro Measurement of Oxygen Consumption Rate
【2h】

Quantification of Low-Level Drug Effects Using Real-Time in vitro Measurement of Oxygen Consumption Rate

机译:使用实时体外耗氧率测量对低水平药物作用进行定量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is a general need to detect toxic effects of drugs during preclinical screening. We propose that increased sensitivity of xenobiotics toxicity combined with improved in vitro physiological recapitulation will more accurately assess potentially toxic perturbations of cellular biochemistry that are near in vivo pharmacological exposure levels. Importantly, measurement of such cytopathologies avoids activating mechanisms mediating toxicity at suprapharmacologic levels not relevant to in vivo effects. We present a sensitive method to measure changes in oxygen consumption rate (OCR), a well-established parameter reflecting a potential hazard, in response to exposure to pharmacologic levels of drugs using a flow culture system and state of the art oxygen sensing system. We tested metformin and acetaminophen on rat liver slices to illustrate the method. The features of the method include continuous and very stable measurement of OCR over the course of 48 h in liver slices in a continuous flow chamber with the ability to resolve changes as small as 0.3%/h. Kinetic modeling of metformin inhibition of OCR over a wide range of concentrations revealed both a slow and fast mechanism, where the fast mechanism activated only at concentrations above 0.6 mM. For both drugs, small amounts of inhibition were reversible, but higher decrements were irreversible. Overall the study highlights the advantages of measuring low-level toxicity so as to avoid the common extrapolations made about drug toxicity based on effects of drugs tested at suprapharmacologic levels.
机译:通常需要在临床前筛选期间检测药物的毒性作用。我们认为,提高异种生物毒性的敏感性并改善体外生理重现将更准确地评估接近体内药理学暴露水平的细胞生物化学的潜在毒性扰动。重要的是,对此类细胞病理学的测量避免了在与体内作用无关的超药理学水平上介导毒性反应的激活机制。我们提出了一种灵敏的方法来测量氧气消耗率(OCR)的变化,这是一个确定的参数,反映了潜在的危害,可以使用流式培养系统和最先进的氧气传感系统来响应暴露于药物药理水平的情况。我们在大鼠肝切片上测试了二甲双胍和对乙酰氨基酚,以说明该方法。该方法的功能包括在连续流动室内的肝脏切片中在48 h的过程中连续且非常稳定地测量OCR,能够分辨低至0.3%/ h的变化。二甲双胍在宽浓度范围内抑制OCR的动力学模型揭示了一个缓慢的机制和快速的机制,其中快速的机制仅在浓度高于0.6µmM时才被激活。对于这两种药物,少量的抑制作用都是可逆的,但是更高的减量是不可逆的。总体而言,该研究强调了测量低水平毒性的优势,从而避免了基于在超药理学水平上测试的药物的作用而得出的关于药物毒性的常见推断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号